q2 cash flow from operating activities $119 million versus $1.45 billion.
sees fy adjusted ebitda growth of about 6% to 8%.
compname reports q2 earnings per share $30.00.
compname reports q2 adjusted earnings per share 35.7%.
board of directors authorized repurchase of up to $1.0 billion of its common stock.
qtrly decrease in cash provided by operating activities was driven by previously announced early repayment of $695 million of medicare accelerated payments received by us during 2020 and repaid to government during q1 of 2021.
compname reports q1 capital expenditures of $482 million.
compname reports q2 earnings per share of $2.21.
